NCT00771849View on ClinicalTrials.gov

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

May 31, 2004

Conditions
MeningitisMeningococcemia
Interventions
BIOLOGICAL

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

0.5 mL, Intramuscular

BIOLOGICAL

Haemophilus Influenzae Type b (Hib) vaccine

0.5 mL, Intramuscular

Trial Locations (2)

E1 1BB

London

SW17 ORE

London

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00771849 - Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children | Biotech Hunter | Biotech Hunter